SK8793A3 - New pharmaceutical formulations of 5-(2-chlor-1-hydroxyethyl)-4-methylthiazole - Google Patents

New pharmaceutical formulations of 5-(2-chlor-1-hydroxyethyl)-4-methylthiazole Download PDF

Info

Publication number
SK8793A3
SK8793A3 SK8793A SK8793A SK8793A3 SK 8793 A3 SK8793 A3 SK 8793A3 SK 8793 A SK8793 A SK 8793A SK 8793 A SK8793 A SK 8793A SK 8793 A3 SK8793 A3 SK 8793A3
Authority
SK
Slovakia
Prior art keywords
methylthiazole
hydroxyethyl
chloro
solvate
pharmaceutically acceptable
Prior art date
Application number
SK8793A
Other languages
English (en)
Slovak (sk)
Inventor
Bernard Robin Boar
Alan J Cross
Alfred R Green
Curt-Eric Hagberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK8793A3 publication Critical patent/SK8793A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK8793A 1990-08-15 1991-08-07 New pharmaceutical formulations of 5-(2-chlor-1-hydroxyethyl)-4-methylthiazole SK8793A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002659A SE9002659D0 (sv) 1990-08-15 1990-08-15 New pharmaceutical formulations
PCT/SE1991/000522 WO1992003134A1 (en) 1990-08-15 1991-08-07 New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole

Publications (1)

Publication Number Publication Date
SK8793A3 true SK8793A3 (en) 1993-07-07

Family

ID=20380161

Family Applications (1)

Application Number Title Priority Date Filing Date
SK8793A SK8793A3 (en) 1990-08-15 1991-08-07 New pharmaceutical formulations of 5-(2-chlor-1-hydroxyethyl)-4-methylthiazole

Country Status (26)

Country Link
US (1) US5385921A (de)
EP (1) EP0619734B1 (de)
JP (1) JP3094077B2 (de)
AT (1) ATE164066T1 (de)
AU (1) AU657490B2 (de)
BG (1) BG97446A (de)
CA (1) CA2088775A1 (de)
CZ (1) CZ279586B6 (de)
DE (1) DE69129126T2 (de)
DK (1) DK0619734T3 (de)
ES (1) ES2114891T3 (de)
FI (1) FI930608A (de)
HU (1) HUT65821A (de)
IE (1) IE912818A1 (de)
IL (1) IL99169A (de)
IS (1) IS3743A7 (de)
LT (1) LT3978B (de)
LV (1) LV10921B (de)
NO (1) NO303447B1 (de)
NZ (1) NZ239329A (de)
PT (1) PT98688B (de)
RO (1) RO112994B1 (de)
RU (1) RU2093155C1 (de)
SE (1) SE9002659D0 (de)
SK (1) SK8793A3 (de)
WO (1) WO1992003134A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901658D0 (sv) * 1999-05-06 1999-05-06 Astra Ab New formulation
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
US6699866B2 (en) 2001-04-17 2004-03-02 Sepracor Inc. Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
CN103772313B (zh) * 2014-01-02 2015-10-14 郑桂富 一种4-甲基-5-(2-羟乙基)噻唑的合成方法
CN112262814A (zh) * 2020-10-26 2021-01-26 宜宾学院 油樟叶渣发酵床养鸡方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2825966A1 (de) * 1978-06-14 1980-01-03 Basf Ag Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt
GB8600783D0 (en) * 1986-01-14 1986-02-19 Merck Sharp & Dohme N-methyl-d-aspartate receptor antagonists

Also Published As

Publication number Publication date
BG97446A (en) 1994-03-24
IS3743A7 (is) 1992-02-16
NZ239329A (en) 1994-11-25
CZ279586B6 (cs) 1995-05-17
EP0619734B1 (de) 1998-03-18
LTIP1714A (en) 1995-09-25
IL99169A0 (en) 1992-07-15
IL99169A (en) 1995-10-31
HU9300388D0 (en) 1993-04-28
LV10921A (lv) 1995-12-20
HUT65821A (en) 1994-07-28
PT98688A (pt) 1992-07-31
CZ16693A3 (en) 1994-02-16
SE9002659D0 (sv) 1990-08-15
LT3978B (en) 1996-06-25
RU2093155C1 (ru) 1997-10-20
NO930452L (no) 1993-02-09
JP3094077B2 (ja) 2000-10-03
FI930608A0 (fi) 1993-02-11
AU657490B2 (en) 1995-03-16
NO930452D0 (no) 1993-02-09
DE69129126D1 (de) 1998-04-23
AU8409291A (en) 1992-03-17
DK0619734T3 (da) 1998-10-05
NO303447B1 (no) 1998-07-13
WO1992003134A1 (en) 1992-03-05
DE69129126T2 (de) 1998-07-23
LV10921B (en) 1996-08-20
CA2088775A1 (en) 1992-02-16
EP0619734A1 (de) 1994-10-19
FI930608A (fi) 1993-02-11
ES2114891T3 (es) 1998-06-16
JPH06500097A (ja) 1994-01-06
PT98688B (pt) 1999-01-29
ATE164066T1 (de) 1998-04-15
IE912818A1 (en) 1992-02-26
RO112994B1 (ro) 1998-03-30
US5385921A (en) 1995-01-31

Similar Documents

Publication Publication Date Title
SK8793A3 (en) New pharmaceutical formulations of 5-(2-chlor-1-hydroxyethyl)-4-methylthiazole
EP3381921B1 (de) Ginkgolid-b-derivat sowie herstellungsverfahren und verwendung davon
US20110269838A1 (en) Novel processes and pure polymorphs
SK160095A3 (en) Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives
EP0929550A1 (de) N-(benzothiazol-2-yl)piperidine-1-ethanamine derivate, ihre herstellung und therapeutische verwendung
CA3038382C (en) Substituted phenylpropionic acid enantiomer and manufacturing method, composition, and application of same
JP2579116B2 (ja) 新規な４−メチル−１，３−オキサゾール化合物、それらの調製法およびそれらを含む医薬組成物
CN110452168B (zh) N-苯基-n-喹啉羧酸类化合物及其制法和药物用途
JP3001975B2 (ja) 結晶性チアガビン塩酸塩−水和物、その製造方法および用途
JPS58210063A (ja) 新規なジヒドロピリジン類
HU214591B (hu) Eljárás egy naftoxazinszármazék malonátsójának és az ilyen hatóanyagot tartalmazó gyógyszerkészítmények előállítására
JPH0440356B2 (de)
FR2683817A1 (fr) Nouveaux derives d'alpha-amino n-pyridyl benzene propanamide, leurs procedes de preparation, compositions pharmaceutiques les contenant.
CN107540672A (zh) 一种治疗肝硬化的药物及其合成方法
DD283372A5 (de) Verfahren zur herstellung von aminoketonen und -alkoholen
JPS59148719A (ja) 抗炎症組成物